No, I’m saying name a merging company that is worth less than $50m. For example, DR*FS (which got up to a market cap of $150m earlier this year) is an offshoot of White Knight which owns NX*MH which has a market cap of 3 billion dollars. They are a worldwide food production corporation. That would definitely not be less than a $50m company. In fact, that kind of proves my point that the companies merging into the OTC are huge this year.
Your entire argument is that 8Mile is merging a company that is, essentially, valueless into the OTC. I’m saying that isn’t possible and show me one company that has merged that is worth less than $50m. Apparently, you can’t even do that. Real companies are merging into the OTC.
Technically you can probably find a pharmaceutical startup but even then the company will often have some value noted such as amount of funds raised or projected returns.
So, go ahead, name a company that has reverse merged with a shell in the last year and the company is worth less than $50m.
Market Data 
Markets 
AI
